Delivery Order SPE2DB24D2010-SPE2DB26FZSC2
Award Date 10/30/25
Potential Completion Date 10/31/25
Potential Value $36K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,086.55 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 (60 doses), a combination respiratory medication used to treat chronic obstructive pulmonary disease. The contract was awarded on September 8, 2025, with an ultimate completion date of September 9, 2025, and is classified as a firm fixed price delivery order with no set-aside designation. Performance will take place at the vendor's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,585.83 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a competitively awarded non-set-aside contract. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $26,582.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation medication used to treat chronic obstructive pulmonary disease. The contract was competitively awarded with no set-aside designation and is set for completion by August 4, 2025. This delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,267.83 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination respiratory medication used in the treatment of chronic obstructive pulmonary disease. Awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, this firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement. The contract will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $44,103.30 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 (60-count units), a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed-price, competitively awarded contract was issued on September 19, 2025, with an ultimate completion date of September 22, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,175.14 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a prescription respiratory medication used to treat chronic obstructive pulmonary disease. The contract was competitively awarded with firm fixed pricing and is classified as a non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 26,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,251.90 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination respiratory medication used to treat chronic obstructive pulmonary disease (COPD). This competitively awarded, firm fixed-price delivery order was issued on September 16, 2025, with an ultimate completion date of September 17, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $7,069.90 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by June 10, 2025. The contract represents a single transaction under AmerisourceBergen's larger pharmaceutical supply framework with the...
- The Defense Logistics Agency awarded a $13,601.21 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, awarded on August 28, 2025, represents a non-competed transaction executed under an existing contract vehicle and is scheduled for completion by August 29, 2025. The pharmaceutical products will be delivered to the company's distribution...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,656.74 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 (60-count units), a combination respiratory medication used to treat chronic obstructive pulmonary disease. The award, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this pharmaceutical distributor. The place of...